Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 10 | 2 | 2005 | 2018 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.090 | None | 1.000 | 9 | 3 | 2001 | 2019 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2011 | 2019 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2010 | 2019 | ||||||||
|
suppressor of cytokine signaling 3 | 0.434 | 0.808 | 0.75 |
|
group | 0.080 | None | 1.000 | 8 | 1 | 2008 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2007 | 2017 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2010 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.070 | None | 1.000 | 3 | 0 | 2002 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2011 | 2013 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
group | 0.060 | None | 1.000 | 6 | 1 | 2009 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2011 | 2013 | ||||||||
|
homeobox A9 | 0.521 | 0.692 | 4.4E-05 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2001 | 2013 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2011 | 2013 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2011 | 2013 | ||||||||
|
interleukin 18 receptor 1 | 0.473 | 0.808 | 8.6E-06 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
nuclear factor, erythroid 2 | 0.628 | 0.577 | 0.67 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2010 | 2019 | ||||||||
|
Epstein-Barr virus induced 3 | 0.474 | 0.808 | 0.11 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
CD177 molecule | 0.595 | 0.654 |
|
group | 0.060 | None | 1.000 | 5 | 0 | 2003 | 2015 | |||||||||
|
suppressor of cytokine signaling 1 | 0.445 | 0.808 | 0.59 |
|
group | 0.060 | None | 1.000 | 5 | 0 | 2007 | 2017 | ||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
group | 0.050 | None | 0.800 | 5 | 0 | 2005 | 2019 | |||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1988 | 2018 | ||||||||
|
envoplakin | 0.599 | 0.423 | 5.7E-25 |
|
group | 0.050 | None | 0.800 | 5 | 0 | 1998 | 2007 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
group | 0.050 | None | 0.800 | 5 | 0 | 2005 | 2019 | |||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2006 | 2016 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2010 | 2019 |